---
figid: PMC7464074__cancers-12-02081-g001
figtitle: HER2 signaling pathway, mechanism of action of targeted therapies, and resistance
  mechanisms
organisms:
- NA
pmcid: PMC7464074
filename: cancers-12-02081-g001.jpg
figlink: pmc/articles/PMC7464074/figure/cancers-12-02081-f001/
number: F1
caption: HER2 signaling pathway, mechanism of action of targeted therapies, and resistance
  mechanisms. 1. The truncated P95HER2 isoform results in the loss of the extracellular
  binding site for trastuzumab. 2.–3. Overexpression of other tyrosine kinase receptors,
  such as IGF1-R and C-met, can continue to trigger downstream signaling despite blockade
  by trastuzumab. 4. Mutations or loss of PTEN constitutively activates the PI3K signaling
  pathway.
papertitle: The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer.
reftext: Aena Patel, et al. Cancers (Basel). 2020 Aug;12(8):2081.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9759037
figid_alias: PMC7464074__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC7464074__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7464074__cancers-12-02081-g001.html
  '@type': Dataset
  description: HER2 signaling pathway, mechanism of action of targeted therapies,
    and resistance mechanisms. 1. The truncated P95HER2 isoform results in the loss
    of the extracellular binding site for trastuzumab. 2.–3. Overexpression of other
    tyrosine kinase receptors, such as IGF1-R and C-met, can continue to trigger downstream
    signaling despite blockade by trastuzumab. 4. Mutations or loss of PTEN constitutively
    activates the PI3K signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Pdk
  - Pdk1
  - Akt
  - mnb
  - Lam
  - wg
  - mAChR-A
  - Gld2
  - Pdp1
  - Hex-A
  - tal-1A
  - sbRNA:1
  - Pten
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Mtor
  - Tor
  - CycE
  - cyc
  - IGF1R
  - EGFR
  - ERBB2
  - ERBB3
  - ERBB4
  - MET
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - AKT1
  - AKT2
  - AKT3
  - DMPK
  - IGHD1-7
  - PTEN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
---
